Top Markets
#1 Pons Pons +59.34%
#2 Purr Purr +54.08%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 Non-Playable Coin Non-Playable Coin +34.40%
#5 TENDIES TENDIES +28.49%
#6 Cash Cat Cash Cat +27.00%
#7 Morpho Morpho +24.89%
#8 Kinetiq Kinetiq +24.27%
#9 StonkBroker StonkBroker +22.49%
#10 ApeX ApeX +22.18%
Coin of the day
Pons Pons
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Peringkat dalam Saham #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Harga Saham
$2.22
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$117.70M
Perubahan (1 hari)
2.69%
Perubahan (1 tahun)
17.26%
Negara
SE
Perdagangan SynAct Pharma AB (SYNACT)

Kategori

Healthcare
Riwayat hasil dividen untuk SynAct Pharma AB (SYNACT)
Hasil dividen (TTM) dari SynAct Pharma AB (simbol saham: SYNACT) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk SynAct Pharma AB (SYNACT) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH